Myasthenia Gravis Disease Market Market Set to Exceed over USD 2,538.6 Million by 2026 | CAGR 10.8%
Forecast to 2020
Myasthenia Gravis Disease Market Size is Estimated to reach USD 2,538.6 Million by 2026
“Myasthenia Gravis Disease Market By Disease Type (Imaging (X-ray, Computed Tomography, Magnetic Resonance Imaging), Blood Tests, Electrodiagnostic, and Edrophonium Test), By Treatment (Medication, Surgery, HSCT), By End-User (Hospitals, Clinics, Academic Research Institutes) By Region, Segments & Forecast, 2018 -2026” The global Myasthenia Gravis Disease Market is anticipated to exceed USD 2,538.6 Million by 2026 according to a new research published by Polaris Market Research. In 2017, the diagnosis segment dominated the global market, in terms of revenue. Myasthenia gravis disease is characterized by rapid fatigue and weakness of any muscles under person’s voluntary control. Though myasthenia gravis can affect people of any age, it’s more common in women younger than 40 and in men older than 60. In General, myasthenia gravis disease is caused by a breakdown in the normal communication between muscles and nerves. There is no accurate cure for MG disease, however, appropriate and early treatment can help to control symptoms, such as double vision, difficulties with speech, chewing, swallowing and breathing, weakness of arm or leg muscles, and drooping of eyelids. The global Myasthenia Gravis Disease market is majorly driven by the need to prevent declining quality of life owing to myasthenia gravis disease. Moreover, growing R&D initiatives for novel therapies are another factor boosting the market growth. In addition, key players are also involved in innovative research to launch the affordable therapeutics for such disease. However, the unfamiliarity with early symptoms as well as signs and high cost associated with the treatment are factors hampering the market growth. Browse Detailed Research Report On Myasthenia Gravis Disease Market: https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-market The global Myasthenia Gravis Disease Market is segmented on the basis of diagnosis, treatment, end-user, and region. On the basis of diagnosis, the market is categorized into Imaging, Blood Tests, Electrodiagnostic, and Edrophonium Test. The imaging segment is further bifurcated into X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and others. On the basis of treatment, the market is segmented into Medication, Surgery, and HSCT. The end-user is further segmented in to Hospitals, Clinics, and Academic Research Institutes. Geographically, North America accounted for the largest share in the global Myasthenia Gravis Disease Market in 2017. The major factors accounted for the high market growth includes high occurrence of disease such in North America. Moreover, Asia Pacific is estimated to generate the lucrative market growth during the forecast period. Growing initiatives by government and private organizations for generating novel control treatment are factors estimated to propel the myasthenia -2-
Myasthenia Gravis Disease Market Size is Estimated to reach USD 2,538.6 Million by 2026
gravis disease market growth in Asia Pacific. In addition, increasing awareness about neuromuscular disorders and vast improvement are boosting the market growth in APAC.
Global Myasthenia Gravis Disease Market Share, By Diagnosis, 2017 & 2026
The leading companies profiled in the Myasthenia Gravis Disease Market report include Alexion Pharmaceutical Inc., Avadel Pharmaceuticals plc, CSL Behring, Grifols S.A., Baxter International Inc., Shire plc, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, and Valeant Pharmaceuticals International Inc. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers. Request for sample: https://www.polarismarketresearch.com/industry-analysis/myastheniagravis-disease-market/request-for-sample
Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources 1.3.2. Secondary data sources 1.4. Key take-away 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Myasthenia Gravis Disease Market Insights 3.1. Myasthenia Gravis Disease Therapies – Industry snapshot -3-
Myasthenia Gravis Disease Market Size is Estimated to reach USD 2,538.6 Million by 2026
4.
5.
6.
7.
8.
3.2. Myasthenia Gravis Disease Therapies - Ecosystem analysis 3.3. Myasthenia Gravis Disease Market Dynamics 3.3.1. Myasthenia Gravis Disease Therapies – Market Forces 3.3.1.1. Myasthenia Gravis Disease Market Driver Analysis 3.3.1.2. Myasthenia Gravis Disease Market Restraint/Challenges analysis 3.3.1.3. Myasthenia Gravis Disease Market Opportunity Analysis 3.4. Industry analysis - Porter's five force 3.4.1. Bargaining power of supplier 3.4.2. Bargaining power of buyer 3.4.3. Threat of substitute 3.4.4. Threat of new entrant 3.4.5. Degree of competition 3.5. Myasthenia Gravis Disease Market PEST Analysis 3.6. Myasthenia Gravis Disease Market Value Chain Analysis 3.7. Myasthenia Gravis Disease Therapies Industry Trends 3.8. Competitive Ranking Analysis, 2017 Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by Diagnosis 4.1. Key Findings 4.2. Imaging 4.2.1. X-ray 4.2.2. Computed Tomography (CT) 4.2.3. Magnetic Resonance Imaging (MRI) 4.2.4. Others 4.3. Blood Tests 4.4. Electrodiagnostic 4.5. Edrophonium Test Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by Treatment 5.1. Key Findings 5.2. Medication 5.3. Surgery 5.4. HSCT Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by End User 6.1. Key Findings 6.2. Hospitals 6.3. Clinics 6.4. Academic Research Institutes Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by Region 7.1. Key Findings 7.2. North America 7.2.1. U.S. 7.2.2. Canada 7.3. Europe 7.3.1. Germany 7.3.2. UK 7.3.3. France 7.4. Asia-Pacific 7.4.1. China 7.4.2. India 7.4.3. Japan 7.5. Latin America 7.5.1. Brazil 7.5.2. Mexico 7.6. Middle East & Africa Company Profiles 8.1. Alexion Pharmaceutical Inc. -4-
Myasthenia Gravis Disease Market Size is Estimated to reach USD 2,538.6 Million by 2026
8.1.1. Overview 8.1.2. Financials 8.1.3. Product Benchmarking 8.1.4. Recent Developments 8.2. Avadel Pharmaceuticals Plc 8.2.1. Overview 8.2.2. Financials 8.2.3. Product Benchmarking 8.2.4. Recent Developments 8.3. CSL Behring 8.3.1. Overview 8.3.2. Financials 8.3.3. Product Benchmarking 8.3.4. Recent Developments 8.4. Grifols S.A. 8.4.1. Overview 8.4.2. Financials 8.4.3. Product Benchmarking 8.4.4. Recent Developments 8.5. Baxter International Inc. 8.5.1. Overview 8.5.2. Financials 8.5.3. Product Benchmarking 8.5.4. Recent Developments 8.6. Shire Plc 8.6.1. Overview 8.6.2. Financials 8.6.3. Product Benchmarking 8.6.4. Recent Developments 8.7. Novartis AG 8.7.1. Overview 8.7.2. Financials 8.7.3. Product Benchmarking 8.7.4. Recent Developments 8.8. Hoffmann-La Roche AG 8.8.1. Overview 8.8.2. Financials 8.8.3. Product Benchmarking 8.8.4. Recent Developments 8.9. Takeda Pharmaceutical Company Limited 8.9.1. Overview 8.9.2. Financials 8.9.3. Product Benchmarking 8.9.4. Recent Developments 8.10. Valeant Pharmaceuticals International Inc. 8.10.1. Overview 8.10.2. Financials 8.10.3. Product Benchmarking 8.10.4. Recent Developments Access Press Release on Myasthenia Gravis Disease Market: https://www.polarismarketresearch.com/press-releases/myasthenia-gravis-disease-market
-5-
Myasthenia Gravis Disease Market Size is Estimated to reach USD 2,538.6 Million by 2026
About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com
-6-